I. Jiménez

发表

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

J. Gisbert, I. Bastón-Rey, D. Busquets, 2022, Inflammatory Bowel Diseases.

Abstracts of papers Rational use of drugs

L. L. Rodriguez, C. Torras, G. Raskob, 1989, Pharmaceutisch Weekblad.

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

J. Gisbert, I. Bastón-Rey, D. Busquets, 2022, Journal of clinical medicine.

Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2023, Gut.